Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

21 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Personalized treatment of hepatitis C genotype 1a in Norway and Sweden 2014-2016: a study of treatment outcome in patients with or without resistance-based DAA-therapy.
Kileng H, Kjellin M, Akaberi D, Bergfors A, Duberg AS, Wesslén L, Danielsson A, Gangsøy Kristiansen M, Gutteberg T, Goll R, Lannergård A, Lennerstrand J. Kileng H, et al. Among authors: lannergard a. Scand J Gastroenterol. 2018 Oct-Nov;53(10-11):1347-1353. doi: 10.1080/00365521.2018.1511824. Epub 2018 Nov 5. Scand J Gastroenterol. 2018. PMID: 30394152
Effect of the baseline Y93H resistance-associated substitution in HCV genotype 3 for direct-acting antiviral treatment: real-life experience from a multicenter study in Sweden and Norway.
Kjellin M, Kileng H, Akaberi D, Palanisamy N, Duberg AS, Danielsson A, Kristiansen MG, Nöjd J, Aleman S, Gutteberg T, Goll R, Lannergård A, Lennerstrand J. Kjellin M, et al. Among authors: lannergard a. Scand J Gastroenterol. 2019 Aug;54(8):1042-1050. doi: 10.1080/00365521.2019.1652846. Epub 2019 Aug 19. Scand J Gastroenterol. 2019. PMID: 31424972
Immune function in Swedish élite orienteers.
Lannergård A, Fohlman J, Wesslén L, Rolf C, Friman G. Lannergård A, et al. Scand J Med Sci Sports. 2001 Oct;11(5):274-9. doi: 10.1034/j.1600-0838.2001.110504.x. Scand J Med Sci Sports. 2001. PMID: 11696211
21 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page